Additionally, HNRNPC participated in the malignant behavior such as metastasis and invasion of bladder cancer, and the expression of HNRNPC was dramatically associated with different clinicopathological variables of bladder cancer patients, which indicated it may be promising biomarker 157. This evidence concerns the gene HNRNPC and urinary bladder cancer.